Background and Purpose-Systemic injection of hematopoietic stem cells after ischemic cardiac or neural lesions is one approach to promote tissue repair. However, mechanisms of possible protective or reparative effects are poorly understood. In this study we analyzed the effect of lineage-negative bone marrow-derived hematopoietic stem and precursor cells (Lin Ϫ -HSCs) on ischemic brain injury in mice.
W ithin 24 hours after ischemia, resident microglia become activated and migrate to the lesion site. [1] [2] [3] Furthermore, blood and bone marrow (BM)-derived monocytes are recruited to the lesion and locally adopt a microglialike phenotype. 4 Activated microglial cells and invaded macrophages facilitate removal of cellular debris during the acute phase of ischemia but also release cytotoxic molecules, including inflammatory cytokines, complement factors, as well as free radicals. 5 Although cytokines released after ischemia are considered to have "proinflammatory" as well as "anti-inflammatory" effects, 6 the overall balance of postischemic inflammation appears to be shifted to a proapoptotic outcome resulting in enhanced cell death, exacerbated neuronal loss, and finally, expansion of the infarct size. 3 Immune cell attraction from blood circulation and from the spleen toward the ischemic lesion site is mediated by chemokines released by glial cells, which also play a crucial role in recruitment of BM-derived stem and precursor cells. 7 Thus, the use of exogenous BM-derived stem and precursor cells offers an attractive therapeutic approach in experimental cerebral ischemia. Unselected BM contains at least 2 populations of multipotent stem and progenitor cells, namely hematopoietic stem cells (HSCs), which are included in the lineage-negative (Lin Ϫ -HSCs) population 8, 9 and marrow stromal cells, also termed mesenchymal stem cells. 10 Chopp et al [11] [12] [13] [14] conducted several experiments with BMderived stromal cells in experimental cerebral ischemia. Marrow stromal cell injection resulted in functional improvement and attenuated tissue damage after middle cerebral artery occlusion in rats. [11] [12] [13] Furthermore, stromal cells were shown to migrate into the ischemic boundary zone 15 accompanied by reduced neuronal apoptosis and enhanced neoangiogenesis. 16, 17 Human CD34
ϩ HSCs systemically applied in experimental ischemia of immunocompromised mice 48 hours before stroke were shown to induce long-term neovascularization in the ischemic zone, 18 and human umbilical cord blood cells also acted neuroprotective in experimental cerebral ischemia. 19, 20 However, it is unclear how hematopoietic stem or precursor cells could mediate neuroprotection.
Materials and Methods

Isolation of Lin
؊ -HSCs BM was isolated from green fluorescent protein (GFP) expressing transgenic male mice (C57BL/6-Tg ACTB-EGFP, 1Osb/J; stock number 003291; JAX Laboratory, Bar Harbor, Maine) or C57BL/6 mice (6 to 8 weeks of age; Charles River, Sulzfeld, Germany; JAX Laboratory, Bar Harbor, Maine). Erythrocytes were lysed and Lin Ϫ -HSCs were isolated by removing blood lineage marker-positive cells with immunomagnetic beads (Dynabeads M-450; Dynall; coupled with a sheep antirat antibody) and a cocktail of rat monoclonal antibodies against lineage markers (anti-CD45R/B220, anti-Mac-1, anti-Gr-1, anti-CD4, anti-CD8a, and anti-Ter119, all from BD Biosciences). For flow cytometry analysis (FACScalibur; BD Biosciences), total BM cells or Lin Ϫ -HSCs were stained with biotin-conjugated anti-CD45, antic-Kit (BD Biosciences), or rat anti-CD11b, anti-TER119, anti-Gr-1, anti-B220, anti-CD8, anti-CD4 monoclonal antibodies, or isotype control antibodies (BD Biosciences), followed by FITC-conjugated streptavidin or FITCconjugated goat antirat IgG secondary antibody (Dianova). Live gating was performed with propidium iodide (Sigma).
Induction of Focal Cerebral Ischemia and Intravenous Lin ؊ -HSC Injection
All experimental procedures were performed according to the EU guidelines for the care and use of laboratory animals and approved by local authorities. Adult male C57BL/6 mice (Charles River; Sulzfeld, Germany) were anesthetized, body temperature was maintained at 37°C using a feedback-controlled heating system, and cerebral blood flow was assessed by recording laser Doppler flow to ensure appropriate ischemia (Ͻ30% of initial cerebral blood flow) and reperfusion. Focal cerebral ischemia was induced by transient occlusion (45 minutes) of the middle cerebral artery using the intraluminal filament technique as described earlier. 21 Previously, we demonstrated in the same ischemia paradigm that arterial blood pressure, heart rate, arterial blood gases, and pH stay within their physiological range throughout the whole experimental procedure. 22 At 24 hours after onset of ischemia, mice were randomly selected to receive either Lin Ϫ -HSCs (5ϫ10 6 
Infarct Volume Analysis
Infarct volume analysis was performed in Lin Ϫ -HSC-injected and PBS-injected animals at 72 hours after treatment in a blinded fashion. Cryostat sections (10 coronal levels, from 2.1 mm anterior to 3.4 mm posterior of Bregma) were stained with cresyl violet and used for planimetrical determination of infarct sizes using an image analysis system (NIH Image 3.12). The area of infarction was measured by subtracting the nonlesioned area of the left (infarcted) hemisphere from the area of the right (noninfarcted) hemisphere in all sections. The infarct volume resulted from integration of sequential areas based on distances between analyzed sections according to stereotactic brain coordinates. 23 
TUNEL Staining and Quantification of TUNEL-Positive Cells
The terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick-end labeling (TUNEL) method was used to assess postischemic apoptotic cell death. 24 Cryostat sections were fixed, incubated with terminal deoxynucleotidyltransferase enzyme and nucleotide mix, followed by TUNEL blocking reagents according the manufacturer's instruction (Roche Diagnostics-Applied Science). After streptavidin-labeling with Alexa Fluor 594 (1:1000; 1% bovine serum albumin, 0.3% Triton-PBS), sections were counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI; Sigma 23 Spatial analysis of cell distribution within the ischemic hemisphere was performed by categorizing the GFP ϩ cells as described previously. 25
Lineage Marker Analysis of Central Nervous System and Spleen Invaded by Lin ؊ -HSCs
Immunohistochemistry was performed at 72 hours after cell injection using antibodies against CD11b (1:50; rat monoclonal; Serotec), double cortin (1:100; goat polyclonal; Santa Cruz), and glial fibrillary acid protein, followed by Alexa Fluor 594-conjugated goat antirat (1:500; Molecular Probes) or Cy3-conjugated donkey antigoat (1:200; Jackson ImmunoResearch) as secondary antibody, respectively. For Isolectin B4 (IB4) staining, sections were incubated with biotinylated IB4 (1:25; Vector Laboratories), followed by staining with Alexa Fluor 594-conjugated streptavidin (1:500; Molecular Probes). Spleen sections were refixed and immunostained with rat anti-CD45 monoclonal antibody (1:200; BD Pharmingen), followed by a Cy3-conjugated goat antirat secondary antibody (1:200; Dianova). All slices were counterstained with DAPI.
Evaluation of nDNA Content
A quantitative computer-assisted analysis (Software Axioplan Vision) of DAPI fluorescence was performed to determine the ploidy of GFP ϩ cells coexpressing IB4 or CD11b. A DNA index was calculated by measuring the DAPI fluorescence intensity of doublepositive cells as previously described. 26 DNA-indices of 60 doublepositive cells and 10 surrounding endogenous cells were determined (mean DNAϪindexϮSEM).
Characterization of Postischemic Apoptosis
Sections were incubated with a polyclonal rabbit antiactivated Caspase-3 antibody (1:2500; BD Biosciences) and a monoclonal mouse anti-NeuN antibody (1:200; Chemicon), followed by Cy3-conjugated goat antirabbit secondary antibody (1:400; Jackson ImmunoResearch) and an Alexa Fluor 488 goat antimouse secondary antibody (1:400; Molecular Probes), and counterstained with DAPI. The number of cells displaying double labeling for activated Caspase-3 and NeuN was quantified in relation to activated Caspase-3-positive cells (in %) from randomly selected fields.
Quantitative Analysis of Postischemic Inflammation
Lin Ϫ -HSC-treated or PBS-treated mice were perfused with paraformaldehyde (4% in PBS) at 24, 48, or 72 hours after cell or PBS infusion. Brains were sectioned, embedded in paraffin, and IB4 staining was performed using biotinylated IB4 (1:25; Vector Laboratories), followed by incubation with Alexa Fluor 594-conjugated streptavidin (1:500; Molecular Probes). For CD3 staining, sections were incubated with a polyclonal rabbit anti-CD3 antibody (1:100; DakoCytomation), followed by goat antirabbit Cy3-conjugated secondary antibody (1:400; Dianova). All sections were counterstained with DAPI. Number of IB4-positive and CD3-positive cells was determined in ischemic basal ganglia of Lin Ϫ -HSC-treated and PBS-treated mice in a blinded fashion by an independent observer. To standardize cell counts, areas of visual fields at corresponding coronal levels were predefined by stereotactic coordinates. Data are given as number of IB4-positive or CD3-positive cells/mm 2 (meanϮSEM). ϩ Lin Ϫ -HSCs within normal and ischemic brain hemispheres. The number of GFP ϩ cells within ischemic hemispheres increased from 48 to 72 hours after intravenous injection. No cell (ND indicates not detected) was observed in normal brains at 48 hours and very few cells were observed at 72 hours after intravenous injection. Data are presented as meanϮSEM at 48 and 72 hours after Lin Ϫ -HSC injection. Number of independent experiments for ischemic brains, nϭ4 for 48 hours and nϭ6 for 72 hours. Number of independent experiments for normal brains, nϭ3. C, Spatial distribution (parenchymal, perivascular, and meningeal) of GFP ϩ Lin Ϫ -HSCs. The number of GFP ϩ cells within the parenchymal compartment increased between 48 and 72 hours after injection. Number of independent experiments, nϭ4 for 48 hours and nϭ6 for 72 hours. D, Morphometric analysis of GFP ϩ cells within ischemic hemispheres at 48 and 72 hours after injection. Cells were classified according to their morphology in "nonramified," "ramified," "spindle-like," or "atypical." The percentage of round, "nonramified" cells decreased, whereas "ramified," more differentiated cells increased between 48 and 72 hours. Number of independent experiments, nϭ4 for 48 hours and nϭ6 for 72 hours.
Real-Time Reverse-Transcription Polymerase Chain Reaction Analysis of Cytokines and Chemokine Receptor Transcripts in Spleens
Spleens derived from Lin Ϫ -HSC-treated or PBS-treated, ischemic, or nonischemic animals were collected 24 hours after cell injection. RNA was isolated using the RNeasy Mini Kit (Qiagen) and reversetranscribed using SuperScript III Reverse Transcriptase (Invitrogen). Relative quantification by real-time polymerase chain reaction was performed (ABI Prism 5700 Sequence Detection System; Perkin Elmer). Values were normalized to GAPDH gene transcript levels.
Results
Central Nervous System Entry of Lin ؊ -HSCs After Cerebral Ischemia
Transient focal cerebral ischemia was induced in adult C57BL/6 mice using the middle cerebral artery occlusion model. At 24 hours after reperfusion, animals received an intravenous injection of either 5ϫ10 6 lineage-negative hematopoietic precursor and stem cells (Lin Ϫ -HSCs) obtained from BM of adult GFP ϩ transgenic mice. Isolated Lin Ϫ -HSCs were CD45 ϩ and c-kit antigen-positive but lacked expression of blood lineage markers such as CD11b, TER119, Gr-1, B220, CD8, and CD4 ( Figure 1A) . GFP ϩ cells were detected at 48 and 72 hours after intravenous injection in the meninges, the perivascular areas, and the parenchyma of the ischemiaaffected hemisphere ( Figure 1B,C) , as well as in peripheral organs such as spleen, lung, liver, and lymph nodes (data not shown). The number of GFP ϩ cells detected within the ischemic hemisphere increased significantly from 146Ϯ43 cells (meanϮSEM; calculated as cells per hemisphere) at 48 hours to 798Ϯ335 cells at 72 hours after intravenous injection ( Figure 1B ). In total, Ϸ0.02% of injected cells were estimated to migrate into the ischemic hemisphere at 72 hours after injection.
Systemically Applied Lin ؊ -HSCs Adopt a Microglia-like Phenotype Within the Central Nervous System
Morphological analysis of central nervous system-migrated Lin Ϫ -HSCs was performed. 25 At 72 hours after Lin Ϫ -HSC injection, 34% of GFP ϩ cells expressed a "ramified" microglia-like phenotype ( Figure 1D ). Furthermore, GFP ϩ cells were found positive for microglia/macrophage markers (Figure 2A, B) . In detail, 67Ϯ16% (meanϮSEM) of GFP ϩ cells were stained with IB4, and 55Ϯ12% were positive for CD11b. GFP ϩ cells did not colocalize with double cortin or glial fibrillary acidic protein, suggesting a lack of early neuronal or astrocytic differentiation ( Figure 2C ). Additionally, GFP ϩ /IB4 or GFP ϩ /CD11b cells were found to be mononucleated, and their mean DNA index was 0.96Ϯ0.11 when compared to surrounding endogenous cells, demonstrating that GFP ϩ cells within the brain did not derive from fusion or phagocytic events.
Reduced Infarct Volumes and Attenuated Neuronal Apoptosis in Lin ؊ -HSC-Treated Animals
Mice treated with Lin Ϫ -HSCs showed smaller infarct volumes than did PBS-injected animals as determined at 72 hours after treatment ( Figure 2D ). In detail, infarct volumes were 49.3Ϯ4.9% (meanϮSEM) of noninfarcted hemispheres in PBS-control mice, whereas infarct volumes were reduced to 26.8Ϯ4.6% of noninfarcted hemispheres in Lin Ϫ -HSCtreated mice ( Figure 2E ). The number of TUNEL ϩ cells within the peri-infarct areas was significantly reduced from 1450Ϯ204 TUNEL ϩ cells/mm 2 (meanϮSEM) in PBS-treated to 955Ϯ27 TUNEL ϩ cells/mm 2 in Lin Ϫ -HSC-treated animals ( Figure 3A-C) . Double-labeling against the neuronal marker NeuN and activated Caspase-3 demonstrated that 97Ϯ3% (meanϮSD) of apoptotic cells were of neuronal origin (Figure 3C) . Thus, stem cell therapy by Lin Ϫ -HSCs prevented neuronal apoptosis in the peri-infarct zone.
Lin
؊ -HSC Treatment Reduces Postischemic Inflammation
Histochemistry for the macrophage/microglial marker IB4 and the T-cell marker CD3 revealed a significant reduction in IB4 ϩ and CD3 ϩ cells in peri-infarct tissues of Lin Ϫ -HSCtreated mice compared to PBS controls at 72 hours after treatment ( Figure 4A-C) . Lin Ϫ -HSC treatment also resulted in reduced numbers of IB4 ϩ cells (762Ϯ57 vs 972Ϯ84 cells/ mm 2 in PBS controls) at 48 hours and CD3 ϩ cells (377Ϯ45 vs 467Ϯ68 cells/mm 2 in PBS controls) at 24 hours after treatment; however, these differences were not statistically significant ( Figure 4A-C) .
Lin
؊ -HSCs Counter-Regulate Ischemia-Induced Inflammation in the Spleen
Reduced numbers of inflammatory IB4
ϩ and CD3 ϩ cells in ischemic hemispheres of Lin Ϫ -HSC-treated mice were observed before detection of intravenously injected Lin Ϫ -HSCs in the brain. To detect possible homing of Lin Ϫ -HSCs to immune organs, analysis of spleens was performed. The 
GFP
ϩ cells were already detected within the spleen at 24 hours after Lin Ϫ -HSC injection at a density of 86Ϯ23 per cm 2 (meanϮSEM) for ischemic and 67Ϯ28 per cm 2 for normal mice ( Figure 5A, B) . Analysis of ischemia-mediated effects on postischemic proinflammatory and chemokine receptor gene transcription profiles in the spleen revealed that relative gene transcript levels of tumor necrosis factor-␣ and IL-1␤ increased 30.3Ϯ16.9-times (meanϮSEM) and 15.0Ϯ6.2-times (meanϮSEM) at 48 hours after lesion onset, respectively ( Figure 5C ). Furthermore, chemokine receptor gene transcripts chemokine receptor 2 and CX3CR1 were upregulated at 48 hours after cerebral ischemia ( Figure 5D ). These ischemia-induced effects on proinflammatory cytokine and chemokine receptor levels within the spleen were counterregulated by Lin Ϫ -HSCs at 24 hours after intravenous injection. In detail, spleens obtained from Lin Ϫ -HSC-treated mice 
Discussion
In our study, central nervous system entry of GFP ϩ cells derived from BM occurred at 48 to 72 hours after systemic injection. Migration of BM-derived cells into the central nervous system after transplantation has been observed before. 27, 28 In contrast to our data, infiltration of BM-derived cells into ischemic brain parenchyma of irradiated mice occurred within 24 hours after onset of ischemia, 22 possibly because of irradiation-induced alterations of the nervous tissue allowing this earlier attraction and central nervous system entry of BM-derived cells.
We only observed homing of GFP ϩ cells to the spleen within the first 24 hours after injection, which was in accordance with reports showing early and primary homing of hematopoietic progenitor and stem cells to BM and spleen after transplantation. 29, 30 Several BM transplantation approaches in injury models provided evidence of stem cell differentiation and fusion. Whereas transplantation of hematopoietic stem and precursor cells led to engraftment of microglia-like cell types within the healthy central nervous system, 27,28 direct injection of selected (Sca-1 ϩ Thy-1 ϩ c-kit ϩ ) HSCs in a model of spinal cord injury resulted in cell expression of markers typical of astrocytes, oligodendrocytes, and neural precursors. 31 In our model of experimental cerebral ischemia, Lin-Ϫ HSCs showed a macrophage or microglia-like phenotype after central nervous system entry at 72 hours after transplantation, and DNA-indices of GFP ϩ cells indicated absence of cell fusion events. However, transdifferentiation into neuronal or astrocytic cell types cannot be excluded to occur at later time points.
Therapy by Lin Ϫ -HSCs acted neuroprotectively and reduced the infarct size. To understand whether Lin Ϫ -HSCs mediated changes in the cerebral growth factor, micromilieu might be responsible for the observed neuroprotection we performed in vitro in gene transcript analysis of neurotrophic factors (brain-derived neurotrophic factor, basic fibroblast growth factor, glial-derived neurotrophic factor, nerve growth factor, neurotrophin-3, vascular endothelial growth factor, and transforming growth factor-␤) and cytokines (tumor necrosis factor-␣, interferon-␥, IL-1␤) of Lin Ϫ -HSCs before injection. However, we were not able to detect substantial gene transcript levels of trophic factors in Lin Ϫ -HSCs in vitro (data not shown). Furthermore, gene transcript analysis of these neurotrophic factors and cytokines within GFP ϩ cellcontaining ischemic hemispheres did not reveal any significant changes at 72 hours after Lin Ϫ -HSC injection (data not shown). Therefore, a local stem cell-mediated trophic factor support could not be detected in our experiments.
Several reports described a contribution of inflammation to cerebral injury in animal models of cerebral ischemia. [32] [33] [34] Activated microglia and macrophages were increased at 24 hours, T cells were increased at 72 hours, and neutrophils were increased up to 96 hours after ischemia. 35 We observed that Lin Ϫ -HSC therapy reduced the immune cell invasion, particularly T cells and macrophages, of the peri-infarcted areas.
It is known that T cells and monocytes are activated and then recruited from the spleen to the ischemic lesion. In accordance with Offner et al, 36 our data show that proinflammatory cytokine and chemokine receptor gene transcription was induced in the spleen soon after transient cerebral ischemia. Interestingly, Lin Ϫ -HSCs counter-regulated the upregulation of proinflammatory cytokine and chemokine receptor gene transcripts in the spleen, thus preventing the activation of immune gene transcripts in splenocytes. Recently, it was shown that human umbilical cord blood cells prevented CD8 ϩ lymphocyte mobilization from the spleen and had antiapoptotic effects, 37, 38 supporting the idea that the reduced infiltration of T cells and monocytes of the ischemic cerebral tissue is a consequence of a decreased number of cells entering the blood circulation from the spleen. In addition, chemokine receptor 2-deficient mice showed reduced infarct size accompanied by reduced immune cell infiltration in experimental cerebral ischemia. 39 In summary, we demonstrate that intravenous injected Lin Ϫ -HSCs attenuate the peripheral postischemic immune response, reduce immune cell infiltration into ischemic hemispheres, and mediate neuroprotection in the subacute phase after ischemic stroke.
